Industry News
Molecules in prostate tumors might predict whether RT can help prevent recurrence
3/14/2015
A new study has identified a group of molecules in prostate-cancer cells that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels...
Tetanus shot improves patient survival with brain tumor immunotherapy
3/14/2015
An innovative approach using a tetanus booster to prime the immune system enhances the effect of a vaccine therapy for lethal brain tumors, dramatically improving patient survival, according to a...
'Quantum jitters' could form basis of evolution, cancer
3/14/2015
Shape-shifting DNA base pairs can trick the copying machineThe molecular machines that copy DNA in a living cell are amazingly fast and accurate at pairing up the correct bases -- G with C and A...
Honey, I shrunk the ants: How environment controls size
3/14/2015
Groundbreaking epigenetics research has implications for everything from cancer to farmingMcGill researchers have discovered that environmental factors play a crucial role in determining...
When should blood transfusions be given after cardiac surgery?
3/14/2015
New research has shown that patients having heart surgery do not benefit if doctors wait until a patient has become substantially anaemic before giving a transfusion.
Raising legal smoking age to 21 will save 'millions of lost life years' for today's children
3/13/2015
The Institute of Medicine have produced a report on what the public health implications of raising the minimum age of legal access for tobacco products would be.
Germline TP53 mutations in patients with early-onset colorectal cancer
3/13/2015
In a group of patients diagnosed with colorectal cancer at 40 or younger, 1.
A one-two vaccine punch could leave brain tumors vulnerable to the immune system
3/13/2015
A common booster vaccine could improve the effect of a vaccine aimed at treating a type of brain tumor, leading to improvement in patient survival, according to research published in the journal...
Stalled drug trials provide information that needs to be shared
3/13/2015
Lots of potentially useful medical information is getting lost. McGill researchers discovered this when they looked into the lack of reporting of information from "stalled drug" trials in cancer...
Two out of 3 people with invasive cancer are surviving 5 years or more
3/13/2015
Two out of 3 people diagnosed with cancer survive five years or more, according to a CDC study published in Morbidity and Mortality Weekly Report.